USPTO serial 79085223
PLASMEX
Reviewed by CopyMark Law Group
Reg. 4089467Status 404
- Filing date
- Status date
- Registration date
- Jan 24, 2012
- Examiner
- SOBRAL, CHRISTINA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PLASMEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stacey R. Halpern
Stacey R. Halpern KNOBBE MARTENS OLSON & BEAR LLP2040 Main Street, 14th FloorIrvine, CA 92614UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical reagents not for medical or veterinary purposes; protein in raw material form for scientific and medical research; enzymes for scientific and medical research; biochemicals, namely, polypeptides for in vitro and in vivo scientific and research use; biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research use; chemical reagents comprising antibodies not for medical or veterinary purposes; chemical agents for chelating and sequestering; higher fatty acids for use in the field of scientific research, reagents, cosmetics, and pharmaceuticals | SECTION 71 - CANCELLED | — |
| 005 | Anti-cancer preparations; anti-sarcoma preparations; contrasting agent for X-ray imaging; diagnostic reagents for medical purposes; radio-isotope markers for therapeutic or diagnostic use; veterinary preparations for veterinary vaccines; biological preparations for the treatment of cancer, critical limb ischemia, cystic fibrosis, retinitis pigmentosa, AIDS, influenza, and Alzheimer's disease; preparations for gene therapy, namely, introducing genes to human and animal cells, tissues, organs and living bodies, and growth media for medical purposes; vaccines; gene vaccines; vectors for introducing genes to human and animal cells, tissues, organs and living bodies, and growth media for medical use, namely, for gene therapy | SECTION 71 - CANCELLED | — |
| 042 | Testing, inspection, research, or development of pharmaceuticals, cosmetics, or foodstuff; testing, inspection, research, or development of pharmaceutical preparations for gene therapy; testing, inspection, research, or development of vaccines; testing, inspection, research, or development of recombinant proteins; medical, chemical, biochemical, biological and bacteriological research and functional analysis of genes or proteins; testing, inspection, or research related to technologies for manufacturing genetically engineered animals, plants, and vectors; testing, inspection, research, or development of vector technologies, namely, medical and scientific research in the field of genetics and genetic engineering; testing, inspection, or research on agriculture, livestock breeding, or fisheries; testing, inspection, research, or development of chemicals for life science; testing or research on machines and instruments; computer software design, computer programming, or maintenance of computer software; rental of computers or providing computer programs | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DNAVEC CORPORATION
- Other trademarks owned by DNAVEC CORPORATION
- Other trademarks owned by ID Pharma Co., Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named PLASMEX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 23, 2021 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jul 23, 2021 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 26, 2019 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| May 23, 2019 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| May 23, 2019 | INPC | INVALIDATION PROCESSED | — |
| Apr 30, 2019 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Aug 31, 2018 | C71T | CANCELLED SECTION 71 | — |
| Jan 24, 2017 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 1, 2015 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 8, 2012 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 20, 2012 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 20, 2012 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 24, 2012 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 24, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 6, 2012 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 8, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 8, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 19, 2011 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 19, 2011 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 30, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 27, 2011 | ALIE | ASSIGNED TO LIE | — |
| Sep 22, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 21, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 21, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 21, 2011 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 13, 2011 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Apr 13, 2011 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| Apr 13, 2011 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Apr 13, 2011 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 13, 2011 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 13, 2011 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 12, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 12, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 12, 2011 | ALIE | ASSIGNED TO LIE | — |
| Apr 11, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 6, 2011 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 6, 2011 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 9, 2010 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 15, 2010 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 15, 2010 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 15, 2010 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 14, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 14, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 24, 2010 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 20, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 19, 2010 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |